News and Press Releases

PTC Therapeutics to Participate at Upcoming Investor Conferences

4 November 2024 -- New Jersey, US -- PTC Therapeutics, Inc today announced that the company will present a company overview at the following conferences: UBS Global Healthcare ConferenceWednesday, Nov....

Category: Biotechnology, Clinical Trials, Other, Pharmaceutical
Posted: November 4, 2024

PTC Therapeutics Inc. 100 Corporate Court South Plainfield, NJ 07080-2449

Sapio Sciences Enhances Bioanalysis LIMS and ELN with Advanced Immunogenicity Capabilities

Enhancements support ADA and NAb testing workflows, boosting lab efficiency and regulatory compliance for drug development 15 October 2024 – Maryland, US – Sapio Sciences, the science-aware™ lab informatics platform,...

Category: Biotechnology, Drug Discovery
Posted: October 17, 2024

400 East Pratt Street #800 Baltimore, MD 21202

Sterling Pharma Solutions Announces Partnership with Soligenix for the Manufacture of Oncology-Targeted API

3 October 2024 -- Cramlington, UK -- Sterling Pharma Solutions, a global contract development and manufacturing organisation, and Soligenix, a late-stage biopharmaceutical company focused on developing and commercialisation of products...

Category: BioManufacturing, Clinical Trials, Pharmaceutical
Posted: October 3, 2024

Sterling Place, Dudley Cramlington, Northumberland, NE23 7QG, United Kingdom

AzurBio Pharma Launches to Fast-Track European Market Entry for Biopharma Companies with Breakthrough Treatments

1 October 2024 -- Paris, France -- AzurBio Pharma, specializing in bringing innovative pharmaceutical products to European markets and focusing on rare and serious diseases with unmet medical needs, is...

Category: Biotechnology, Clinical Trials, Drug Discovery, Pharmaceutical
Posted: October 1, 2024

32 Av. Kléber, 75116 Paris, France

Sarepta Therapeutics Announces Recipients of LGMD Grant Awards for 2024; Program Supports Early Genetic Testing and Awareness

Recipients awarded a total of more than $100,000 in grants Funding will support education and activities to shorten diagnostic journey. 30 September 2024 -- Massachusetts, US -- Sarepta Therapeutics, Inc, the...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: September 30, 2024

Hill House, 1 Little New Street London, EC4A 3TR United Kingdom

Newcells Biotech launches high-content and high-throughput imaging suite to advance pre-clinical drug development programmes

Investment in state-of-the-art imaging suite to accelerate data generation with physiologically-relevant in vitro models for deeper insights on drug effects in vivo Launch of advanced lung FMT assay provides extensive...

Category: Drug Discovery
Posted: August 8, 2024

Newcells Biotech, The Biophere, Drayman's Way, newcastle Helix, Newcastle-upon-Tyne, NE4 5BX

Deuterium Depletion Is the Key to Getting a Breakthrough in Cancer Therapy

Two review papers consolidate 30 years of research BUDAPEST, Hungary, July 25, 2024 / Biotech Newswire / -- HYD LLC for Cancer Research and Drug Development (HYD or the Company)...

Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: July 25, 2024

1118 Budapest, Villányi út 97., Hungary

Mogrify appoints Dr Jonathan Appleby as chief scientific officer

Strategic hire bolsters executive leadership team as company progresses multiple therapeutic programmes toward and into clinical development 15 July 2024 – Cambridge, UK – Mogrify, a regenerative medicine company developing...

Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: July 15, 2024

25 Cambridge Science Park Milton Rd, Milton, Cambridge CB4 0FW

CatSci Announces Strategic Acquisition of Reach Separations to Offer End-To-End Separation Science Support from Discovery to Manufacture

25 June 2024 - Cardiff, UK - CatSci Ltd, an award-winning innovation partner for medicines development, announces the acquisition of Reach Separations, a specialist chromatography provider for the analysis and purification...

Category: BioManufacturing, Pharmaceutical
Posted: June 25, 2024

CBTC2 Capital Business Park Wentloog, Cardiff CF3 2PX

Bio-Rad Extends Range of Anti-Biotherapeutic Antibodies to Accelerate Antibody Drug Development

Four New Anti-Idiotypic Antibodies and a New Anti-MMAE Antibody Range Support Bioanalytical Assay Development for Preclinical Research and Clinical Trials June 24 2024, California, US, -Bio-Rad Laboratories, Inc. (NYSE: BIO...

Category: BioManufacturing, Clinical Trials, Drug Discovery
Posted: June 24, 2024

Bio-Rad Laboratories Ltd. The Junction Station Road Watford Hertfordshire WD17 1ET

Enterprise Therapeutics publishes preclinical profile of ETD001, a novel inhaled ENaC blocker

Low doses of ETD001 demonstrate exceptionally long duration of action in sheep model of airway mucus clearance Report in Journal of Cystic Fibrosis discloses best-in-class profile of ETD001 ETD001 scheduled...

Category: Biotechnology, Clinical Trials, Drug Delivery, Drug Discovery, Pharmaceutical
Posted: June 12, 2024

Sussex Innovation Centre, University of Sussex, Science Park Square, Falmer, Brighton, BN1 9SB, UK

Altasciences Receives 2024 CRO Leadership Award for Capabilities

16 May 2024 -- Laval, Québec, Canada -- Altasciences announced today that it has been recognised for excellence in contract research with a 2024 CRO Leadership Award for Capabilities. This...

Category: BioManufacturing, Clinical Trials, Pharmaceutical
Posted: June 3, 2024

575 Armand-Frappier Blvd. Laval, QC H7V 4B3 Canada

Biogen Receives European Commission Approval for QALSODY (tofersen), the First Therapy to Treat a Rare, Genetic Form of ALS

SOD1-ALS is a devastating, uniformly fatal and ultra-rare genetic form of ALS estimated to affect less than 1,000 people in Europe QALSODY is Biogen’s third rare disease therapy to be...

Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: May 30, 2024

Biogen International GmbH Neuhofstrasse 30 6340 Baar Switzerland

One2Treat launches ground-breaking treatment-decision approach to clinical research and market access analysis

One2Treat reflects patient priorities in a single comprehensive treatment evaluation, reducing trial sample size and accelerating patient access to new treatments 26 March 2024 -- Brussels, Belgium -- One2Treat, a...

Category: Clinical Trials, Pharmaceutical
Posted: March 26, 2024

Rue Emile Francqui, 1-1435 Mont-Saint-Guibert, Belgium

TMC Pharma champions holistic approach to medical services in rare disease drug development

13 March 2024 – In a recent webinar, rare disease specialist and global clinical research organisation (CRO) TMC Pharma gathered esteemed speakers to share insights into the scope of medical...

Category: Drug Discovery, Pharmaceutical
Posted: March 13, 2024

Lodge Farm Barn Elvetham Park Estate, Fleet Road, Hartley Wintney, Hampshire RG27 8AS, UK